Abiopharma

🔍 Jiang Xiao (Director)

Company: FARADAY FUTURE INTELLIGENT ELECTRIC INC. (FFAI)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 5,825 shares of Class A Common Stock (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,825.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 2,529 shares of Class A Common Stock at $2.79 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,296.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 5,825 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: Each restricted stock unit ("RSU") represented a contingent right to receive one share of Class A common stock of the Company. The RSUs had no exercise or conversion price and were not exercisable. The RSUs were granted on August 17, 2026, vested in full and automatically settled on August 24, 2026 for no consideration. The RSUs had no expiration date
• F2: Represents 2,529 shares sold in connection with the vesting and settlement of RSUs to satisfy applicable employee tax withholding obligations. The shares were sold by the broker and the cash proceeds were remitted to the Company to satisfy the applicable tax withholding obligations.
• F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.66 to $3.10, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price.